The global surgical snares market size valued at USD 1.4 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 4.8% from 2019 to 2026. The market is primarily driven by an increase in factors such as the number of endoscopic ambulatory surgical centers, polypectomy procedures, and preference for minimally invasive surgeries. A significant increase in the number of gastrointestinal procedures in the U.S. and other developed economies is anticipated to support growth over the forecast period.
The surgical snare is a medical instrument primarily used for the removal of unwanted growth within a body cavity, including tumors, tonsils, or polyps. A snare consists of a loop-like structure of wire at the tip of a cannula (thin tube), a handle, and a wire tightening mechanism to efficiently remove a tumor. The easy-to-use mechanism of a snare helps surgeons efficiently remove damaged or cancerous tissues. Snares can also help surgeons remove a biopsy sample to determine if the tissue is cancerous. The ease of use and growing demand are propelling the overall growth of the market.
Increased patient awareness of colorectal cancer is also propelling the market. According to 2019 estimates by the American Cancer Society, every year, around 100,000 U.S. citizens are diagnosed with colon cancer and about 44,000 are diagnosed with rectal cancer. Also, approximately 51,000 deaths are expected due to colorectal cancer in 2019. Furthermore, updated guidelines by the American Cancer Society recommend regular screening through six different tests, including a colonoscopy every ten years for adults at or above the age of 45. Therefore, an increase in the number of screening procedures is fueling growth.
Also, increasing prevalence of chronic kidney diseases, growing geriatric population suffering from chronic conditions, and increasing patient awareness are aiding growth. Favorable reimbursement policies in major markets are also promoting demand and the use of surgical snares in various medical procedures.
According to the 2017 Plastic Surgery Report released by the American Society of Plastic Surgeons, over 17 Million minimally invasive procedures were performed in 2017, a 2% rise from 2016. Procedures such as breast & eyelid surgeries, liposuction, & nose reshaping, as well as other reconstructive surgeries have been witnessing rising demand over the past few years. Thus, the growing demand for surgical procedures in developed and developing economies is expected to indirectly aid the adoption of snares over the forecast period. The aforementioned factors coupled with technological advancements in surgical instruments is expected to drive the global market.
By application, the surgical snare market has been segmented into GI endoscopy, laparoscopy, urology endoscopy, gynecology, arthroscopy, bronchoscopy, mediastinoscopy, laryngoscopy, and others. In 2018, GI endoscopy accounted for the largest market size and is expected to grow at a CAGR of 5.1% over the forecast period. The dominance of the GI endoscopy segment is attributed to a large global geriatric population, high incidence of colorectal cancer, and a consequently large number of polypectomy procedures. The demand for GI endoscopy has increased significantly due to growth in preference for minimally invasive surgeries. Endoscopic procedures are generally considered as low-risk procedures and are also covered by health insurance in several regions.
Arthroscopy is the fastest-growing segment at a CAGR of 5.2% over the forecast period. This can be attributed to a global increase in the prevalence of orthopedic diseases and several orthopedic surgeries. According to WHO, the world’s population aged 60 years and above will double from 11% in 2015 to 22% in 2050. The aging demographic is a core end-user of knee/hip implants and various orthopedic surgeries. Therefore, a growing geriatric population, prone to orthopedic diseases, is propelling growth.
By end-use, the market is segmented into hospitals and ambulatory surgical centers. The hospital segment dominated in 2018 and is expected to maintain its lead over the forecast period. Its leading market share is attributed to the availability of skilled healthcare professionals, increased government funding, and increasing private sector investment into healthcare.
The ambulatory surgical center segment is expected to grow at a CAGR of 5.1% over the forecast period. This is attributed to an increase in the number of endoscopy ambulatory surgical centers & the availability of same-day procedures, as well as a reduction in the cost of treatment & hospital stay.
North America dominated in 2018 and is expected to maintain its position over the forecast period. Major factors contributing to its growth include favorable reimbursement policies, local presence of key players, and government initiatives that enable access to colorectal cancer screening programs. The stigma attached to the procedure has also reduced over time and many people have been made aware of the fact that colonoscopy checks every five to ten years could increase their chances of early detection of life-threatening cancer, thereby increasing survival rates.
Europe is growing at a rapid pace and is currently the second-largest region after North America. Its growth can be attributed to favorable reimbursement policies, growing geriatric population, and increasing incidence of diseases that require endoscopy procedures.
Asia Pacific is the fastest-growing segment, at a CAGR of 5.6% over the forecast period, owing to an increase in the geriatric population and a rise in the number of endoscopic surgical procedures, and increasing incidence of colorectal cancer & associated mortality. Its growth is also attributed to increased investments in key countries, such as Japan, China, India, Australia, and South Korea.
Olympus Corporation, a market leader in surgical snares, offers a wide range of products through its medical business segment. It has a global presence and holds major shares in North America, Europe, and the Asia Pacific. Most key players in this market are focused on product launches and mergers & acquisitions to enter or maintain their position. For instance, in 2018, Cook Medical launched two new products: Cook Needle’s Eye Snare and Cook Lead Extraction System. In 2017, Merit Medical System acquired assets from Catheter Connections, Inc. and Argon Medical Devices. These acquisitions enhanced Merit’s product offering and geographic presence. Some of the prominent players in the surgical snares market include:
Olympus Corporation
Boston Scientific
Cook Medical
CONMED Corporation
Medtronic
Steris (U.S.)
Medline Industries
Merit Medical Systems
Avalign Technologies
Hill-Rom Holdings, Inc.
Sklar Surgical Instruments
Report Attribute |
Details |
The market size value in 2020 |
USD 1,515.9 million |
The revenue forecast in 2026 |
USD 1,980.4 million |
Growth Rate |
CAGR of 4.8% from 2019 to 2026 |
The base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Device usability, application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain China; Japan; India; Australia; South Korea; Mexico; Brazil; Colombia; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Olympus Corporation; Boston Scientific; Cook Medical; CONMED Corporation; Medtronic; Steris (U.S.); Medline Industries; Merit Medical Systems; Avalign Technologies; Hill-Rom Holdings; Inc.; Sklar Surgical Instruments |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the surgical snares market report based on device usability, application, and end-use:
Usability Outlook (Revenue, USD Million, 2015 - 2026)
Single-Use
Reusable
Application Outlook (Revenue, USD Million, 2015 - 2026)
GI Endoscopy
Laparoscopy
Urology Endoscopy
Gynecology Endoscopy
Arthroscopy
Bronchoscopy
Mediastinoscopy
Laryngoscopy
Others
End-use Outlook (Revenue, USD Million, 2015 - 2026)
Hospitals
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Colombia
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global surgical snares market size was estimated at USD 1,438.4 million in 2019 and is expected to reach USD 1,515.9 million in 2020.
b. The global surgical snares market is expected to grow at a compound annual growth rate of 4.8% from 2019 to 2026 to reach USD 1,980.4 million by 2026.
b. North America dominated the surgical snares market with a share of 45.3% in 2019. This is attributable to favorable reimbursement policies, local presence of key players, and government initiatives that enable access to colorectal cancer screening programs.
b. The key players operating in the surgical snares market are Olympus Corporation, Boston Scientific, Cook Medical, CONMED Corporation, Medtronic, Steris (U.S.), Medline Industries, Merit Medical Systems, Avalign Technologies, Hill-Rom Holdings, Inc., and Sklar Surgical Instruments.
b. Key factors driving the market growth include increasing number of surgical procedures, increasing healthcare spending, rising incidence of colorectal cancer and rising geriatric population worldwide.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.